Biocon Takes Its Oncology Biosimilars To 30 Countries In Africa And Asia
Enables Access To Trastuzumab And Pegfilgrastim Through Cancer Access Partnership
• By Akriti Seth
Biocon plans to launch oncology biosimilars in 25 African countries and five Asian countries • Source: Shutterstock 
